NASDAQ:CNSP | Profit Breakdown | CNS Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$2.7M-$2.59M
2026-03-31-$4.98M-$4.94M
2025-12-31-$5.99M-$5.96M
2025-09-30-$3.25M-$3.22M
2025-06-30-$2.41M-$2.38M
2025-03-31-$4.34M-$4.3M
2024-12-31-$3.2M-$3.18M
2024-09-30-$5.63M-$5.61M
2024-06-30-$2.53M-$2.53M
2024-03-31-$3.54M-$3.54M
2023-12-31-$5.38M-$5.38M
2023-09-30-$4.53M-$4.52M
2023-06-30-$4.03M-$4.02M
2023-03-31-$4.93M-$4.93M
2022-12-31-$5.13M-$5.14M
2022-09-30-$3.42M-$3.42M
2022-06-30-$3.56M-$3.57M
2022-03-31-$3.15M-$3.15M
2021-12-31-$3.25M-$3.25M
2021-09-30-$3.81M-$3.81M
2021-06-30-$3.81M-$3.81M
2021-03-31-$3.61M-$3.61M
2020-12-31-$3M-$3M
2020-09-30-$2.01M-$2.01M
2020-06-30-$2.47M-$2.47M
2020-03-31-$1.97M-$1.97M
2019-12-31-$2.52M-$2.53M
2019-09-30-$699,094.00-$706,655.00
2019-06-30-$415,062.00-$431,707.00
2019-03-31-$195,090.00-$211,501.00
2018-12-31-$208,583.00-$6.63M
2018-09-30-$169,905.00-$193,204.00
2018-06-30-$257,483.00
2018-03-31-$309,699.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$15.99M-$15.85M
2024-12-31-$14.9M-$14.86M
2023-12-31-$18.87M-$18.85M
2022-12-31-$15.27M-$15.27M
2021-12-31-$14.49M-$14.5M
2020-12-31-$9.45M-$9.46M
2019-12-31-$3.83M-$3.88M
2018-12-31-$881,787.00-$7.39M